Literature DB >> 4371131

A clinicopathological review of 100 cases of primary malignant tumours of the liver.

R N MacSween.   

Abstract

One hundred cases of primary malignant tumour of the liver coming to necropsy in the period 1900-1969 have been reviewed. The overall tumour incidence was 0.46% of all necropsies. The overall tumour incidence in hepatic cirrhosis was 12.3%, but the corresponding male and female incidences were 17.5 and 4.4% respectively. There was no significantly increased tumour incidence in haemochromatosis. An increasing incidence of primary malignant tumours of the liver has been noted since 1940 and appears to be due to a corresponding increase in incidence of hepatic cirrhosis. Hepatocellular carcinomas outnumbered cholangiocarcinomas by 8 to 1, were more common in males than females (6 to 1), and in 77% of cases occurred in cirrhotic livers. Tumours supervened as a complication of macronodular or predominantly macronodular cirrhotic patterns.

Entities:  

Mesh:

Year:  1974        PMID: 4371131      PMCID: PMC475426          DOI: 10.1136/jcp.27.8.669

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  33 in total

1.  Primary and metastatic carcinoma of the liver. Relationship to hepatic cirrhosis.

Authors:  E A GALL
Journal:  Arch Pathol       Date:  1960-08

2.  Posthepatitic, postnecrotic, and nutritional cirrhosis: a pathologic analysis.

Authors:  E A GALL
Journal:  Am J Pathol       Date:  1960-03       Impact factor: 4.307

3.  The natural history of postnecrotic cirrhosis; a study of 221 autopsy cases.

Authors:  R A MACDONALD; G K MALLORY
Journal:  Am J Med       Date:  1958-03       Impact factor: 4.965

4.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

5.  Primary carcinoma of the liver in hemochromatosis.

Authors:  S WARREN; W L DRAKE
Journal:  Am J Pathol       Date:  1951 Jul-Aug       Impact factor: 4.307

6.  Primary malignant tumors of the liver.

Authors:  A A el-Domeiri; A G Huvos; H S Goldsmith; F W Foote
Journal:  Cancer       Date:  1971-01       Impact factor: 6.860

Review 7.  Survival after liver resection for cancer.

Authors:  J H Foster
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

8.  Cirrhosis and primary cancer of the liver. Comparative study in Tokyo and Cincinnati.

Authors:  W Mori
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

9.  Precancerous condition of the human liver.

Authors:  T Takahashi; T Orii; M Kaneda
Journal:  Tohoku J Exp Med       Date:  1968-02       Impact factor: 1.848

10.  Serum alpha-feto-protein. VII. The range of apparent serum values in normal people, pregnant women, and primary liver cancer high risk populations.

Authors:  L R Purves; W R Branch; E W Geddes; C Manso; M Portugal
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

View more
  10 in total

Review 1.  Cirrhosis of the liver. A regenerative process.

Authors:  F Callea; M Brisigotti; G Fabbretti; R Sciot; P Van Eyken; M Favret
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

2.  Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma.

Authors:  M L Turbitt; R S Patrick; R B Goudie; W M Buchanan
Journal:  J Clin Pathol       Date:  1977-12       Impact factor: 3.411

3.  Hepatocellular carcinoma and hepatic cirrhosis in the west of Scotland: a 25-year necropsy review.

Authors:  R A Burnett; R S Patrick; W G Spilg; W M Buchanan; R N Macsween
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

4.  Cirrhosis and hepatocellular carcinoma: a 13 year necropsy study with attention to the role of alcohol.

Authors:  G S McDonald; G P Boran; D G Weir
Journal:  Ir J Med Sci       Date:  1985-04       Impact factor: 1.568

5.  The morphological spectrum of peripheral intrahepatic cholangiocarcinoma--an attempt at histological classification of twenty-eight autopsy cases.

Authors:  Y H Xu; R L Peters
Journal:  J Tongji Med Univ       Date:  1986

6.  Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.

Authors:  P J Johnson; N Krasner; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

7.  Angiosarcoma of the liver: annual occurrence and aetiology in Great Britain.

Authors:  P J Baxter; P P Anthony; R N Macsween; P J Scheuer
Journal:  Br J Ind Med       Date:  1980-08

8.  Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma.

Authors:  P J Johnson; W M Melia; M K Palmer; B Portmann; R Williams
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

9.  Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976.

Authors:  J B Gibson; P C Wu; J C Ho; I J Lauder
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

10.  Utility of Cytokeratin7 Immunocytochemistry in the Cytopathological Diagnosis of Fibrolamellar Hepatocellular Carcinoma.

Authors:  Rashi Garg; Radhika Srinivasan; Pranab Dey; Priya Singh; Nalini Gupta; Arvind Rajwanshi
Journal:  J Cytol       Date:  2018 Apr-Jun       Impact factor: 1.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.